Metraipolis › archive › dc_32c151bce33e

Ripk2 promotes CD8+ T cell inactivation and hepatocellular carcinoma progression through Myb/Cxcl9 and Pax5/Adpgk signaling pathways — Europe PMC PMID:42215445

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42215445
DOI
10.1038/s41419-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-08T16:17:14.977Z
SHA-256 of the archived text
9ac2fa77f34e651acb7302f60c641f7614eb4221a3cae175be071431d35fb476
Stable URL of this page
https://metraipolis.com/documento/dc_32c151bce33e

How to cite

Ripk2 promotes CD8+ T cell inactivation and hepatocellular carcinoma progression through Myb/Cxcl9 and Pax5/Adpgk signaling pathways — Europe PMC PMID:42215445 — Europe PMC (en), https://europepmc.org/article/MED/42215445 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32c151bce33e (Metraipolis archive dc_32c151bce33e, sha256 9ac2fa77f34e651acb7302f60c641f7614eb4221a3cae175be071431d35fb476)
BibTeX
@misc{dc32c151bce33e,
  title = {Ripk2 promotes CD8+ T cell inactivation and hepatocellular carcinoma progression through Myb/Cxcl9 and Pax5/Adpgk signaling pathways — Europe PMC PMID:42215445},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42215445},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32c151bce33e; sha256 9ac2fa77f34e651acb7302f60c641f7614eb4221a3cae175be071431d35fb476},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42215445. Agents can read the archived copy with the MCP tool read_document.